«We were excited to see that in
human liver tumors mTORC1 signaling correlates with FGF21 expression,» comments cell biologist Dr. Marion Cornu and first author of the study.
Activated mTORC1 signaling (top) correlates with increased FGF21 expression (below) in
human liver tumor.
Not exact matches
Researchers have injected mice with
human breast, ovary, colon, bladder, brain,
liver and prostate
tumors, and their new drug has killed the
tumors every time.
So he implanted various
human tumors — including ovarian, breast, colon,
liver, and brain — into mice and then injected the animals with antibodies that disable CD47.
A virus that has shown promise as a vector for
human gene therapy causes
liver tumors in neonatal mice.
Similar to
humans, the mice developed
tumors at secondary sites including the
liver, lung, peritoneum, and diaphragm.
Rather than artificially triggering cancer by engineering genetic mutations, this model more closely mimics
human liver cancer in that
tumors develop as a natural consequence of non-alcoholic steatohepatitis (NASH), a chronic metabolic disorder that causes
liver damage, fibrosis and numerous cell mutations.
In
humans, colon cancer often spreads to the
liver and forms small
tumors that are difficult to detect, similar to ovarian
tumors.
Researchers from Charité — Universitätsmedizin Berlin, the Medical University of Graz and the German Institute of
Human Nutrition in Potsdam - Rehbruecke have found that p53, one of the most important
tumor suppressors, accumulates in
liver after food withdrawal.
Once formed, many of these experimental
tumors spread to the
liver, just like
human colon cancers often do.
«New MRI approach detects early
liver tumors in mouse model of
human disease.»
↵ 3 The abbreviations used are: HUVEC,
human umbilical vein endothelial cell; DiI - Ac - LDL, 1,1 ′ - dioctadecyl - 3,3,3 ′, 3 ′ - tetramethyl - indocarbocyanine acetylated low - density lipoprotein; FACS, fluorescence - activated cell sorting; FGFR, fibroblast growth factor receptor; Flk, fetal
liver kinase; ICAM, intercellular adhesion molecule; mAb, monoclonal antibody; PE, phycoerythrin; TNF,
tumor necrosis factor; VCAM, vascular cell adhesion molecule.
Additionally, overexpression of POSTN in
human mammary epithelial and breast cancer cells resulted in enhanced
tumor growth and metastasis (Wang et al., 2013), which is similar to a colon cancer cell model where overexpression of POSTN resulted in an increase in the number and size of
liver metastases (Bao et al., 2004).
In fact, large
human liver cancer
tumors on comparatively small mice started regressing about 20 days after treatment, and were eradicated by day 41 with the help of one of the targeted receptors.
Next steps include He's collaboration with Piedmont Atlanta Hospital to retrieve T cells,
liver cancer cells and healthy tissue normally removed from patients during surgery, put the mouse receptor genes on these T cells and monitor in a dish both how those cells now fight the
tumor and react to healthy
human tissue.
Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in
human solid
tumors, including brain, breast, prostate, pancreas,
liver, ovary, skin, colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).
For this study, the researchers closely examined an ordinary
tumor removed from a
human liver.
Studying cells from the stomach and pancreas in
humans and mice, as well as mouse kidney and
liver cells, and cells from more than 800
tumor and precancerous lesions in people, the researchers found when tissue is injured by infections or trauma, mature cells can revert back to a stem - cell state in which they divide repeatedly.
Still, by the 1990s DuPont knew that the chemical caused cancerous
tumors in the testes, pancreases, and
livers of lab animals, and there was even evidence of
human DNA damage and links to prostate cancer in workers exposed to PFOA.
This finding was reinforced by an animal study, in which tocotrienol inhibited
tumor growth in mice that had been injected with
human liver cancer cells.
This evidence stems from the fact that eating foods that resemble the protein structure of
humans causes the
liver to release excess amounts of the growth hormone, IGF - 1, which accelerates aging and promotes
tumor growth.
Phytates have been shown to inhibit the growth of
human leukemia cells, colon cancer cells, both estrogen receptor - positive and negative breast cancer cells, voicebox cancer, cervical cancer, prostate cancer,
liver tumors, pancreatic, melanoma, and muscle cancers.
«A
human heart that was slowly transforming into bone; cancerous
livers, a cancerous testicle so enlarged by its disease that a special case had to be built to contain it;
tumors sliced from noses, throats.»